Outcome after heart transplantation from donation after circulatory-determined death donors

Simon Messer1, Aravinda Page1, Richard Axell1

  • 1Department of Transplantation, Papworth Hospital National Health Service Foundation Trust, Papworth Everard, Cambridgeshire, United Kingdom.

Insights

Heart transplants from donation after circulatory-determined death (DCD) donors show similar 90-day survival rates compared to donation after brain death (DBD) donors. This approach can expand the donor pool for heart transplantation.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Surgical Innovation

Background:

  • The demand for heart transplants significantly exceeds the supply of donor hearts from donation after brain death (DBD).
  • Donation after circulatory-determined death (DCD) presents a potential supplementary source of donor hearts.
  • This study evaluates the largest single-center experience comparing DCD and DBD heart transplant outcomes.

Purpose of the Study:

  • To compare the outcomes of heart transplantation using DCD donors versus matched DBD donors.
  • To assess the viability of DCD heart donation as an additive strategy to increase heart transplant activity.

Main Methods:

  • A retrospective analysis of 28 DCD heart transplants was conducted.
  • DCD hearts were retrieved using normothermic regional perfusion (NRP) or direct procurement and perfusion (DPP).
  • Outcomes were compared against a matched cohort of DBD heart transplants, with 90-day survival as the primary endpoint.

Main Results:

  • Ninety-day survival rates were comparable between DCD (92%) and DBD (96%) recipients (p = 1.0).
  • Hospital length of stay, rejection episodes, allograft function, and 1-year survival (DCD 86%, DBD 88%) were similar between groups.
  • The retrieval method (NRP vs. DPP) did not impact transplant outcomes.

Conclusions:

  • Heart transplantation from DCD donors yields comparable short-term outcomes to traditional DBD heart transplants.
  • DCD heart donation is a viable strategy to increase heart transplant activity in selected patients.
Abstract